PharmaVoice Logo

Healthcare Leaders Hub

Can smarter technology selection help de-risk small-molecule development?

Pharma Tech

Can smarter technology selection help de-risk small-molecule development?

Predictive modelling for drug formulation helps developers select promising approaches and identify manufacturing challenges earlier.

Read Full Article
Top 20 Countries in Healthcare Innovation 2026 

PharmaShots

Top 20 Countries in Healthcare Innovation 2026 

Shots  Executive Summary  Healthcare-innovation capacity in 2026 is concentrated in small, research-dense health systems, while the world’s largest market still dominates clinical-research scale. PharmaShots scored 35 high-income and major emerging economies on five public indicators (health spending, physician supply, R&D intensity, researcher density and clinical-trial activity). Sweden (84.4), Austria (82.6), Switzerland (81.0), Denmark (75.8) and… The post Top 20 Countries in Healthcare Innovation 2026  appeared first on PharmaShots.

Read Full Article
OrbiMed raises $3bn to back global life science players 

Pharma Tech

OrbiMed raises $3bn to back global life science players 

The duo of funds will support companies across the biopharma, healthcare technology, diagnostics and medical device disciplines.

Read Full Article
Cotecna Group acquires Energon Labs, strengthens global pharma testing capabilities

Express Pharma

Cotecna Group acquires Energon Labs, strengthens global pharma testing capabilities

The acquisition enhances Cotecna's ability to support both Indian and international  customers with high-quality and regulatory-compliant testing services  The post Cotecna Group acquires Energon Labs, strengthens global pharma testing capabilities appeared first on Express Pharma.

Read Full Article
AstraZeneca and insitro forge $1.5bn AI-powered cardiometabolic partnership 

Pharma Tech

AstraZeneca and insitro forge $1.5bn AI-powered cardiometabolic partnership 

This insitro deal sees AstraZeneca double down on its plans to enter the MASH market, which is expected to reach a value of $20.3bn in 2032.

Read Full Article

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

ET Pharma

Oct 17, 2026, 2:46 AM

FDA flags five observations at Zydus’ Moraiya plant

According to a stock exchange filing, the facility was inspected from October 5 to 13.

ET Pharma

Oct 17, 2026, 2:32 AM

Indian, German firms to collaborate on immunoglobulin products: Indian Embassy

The Indian mission facilitated the exchange of a non-disclosure agreement (NDA) between Germany's Neovii Biotech GmbH and India's VINS Bioproducts Ltd on the sidelines of the Indo-German Health Leadership Dialogue on October 13, it said.

PharmaShots

Oct 16, 2026, 4:41 PM

Ascendis Pharma’s TransCon CNP (Navepegritide) Receives the CHMP’s Positive Opinion for Achondroplasia in Children

Shots: The CHMP has adopted a positive opinion recommending EU marketing authorization for Ascendis Pharma’s once-weekly TransCon CNP (navepegritide) for achondroplasia in children aged ≥2yrs. whose epiphyses are not closed; the EC decision on the MAA is expected in Q4’26 The opinion followed review of the MAA, incl. clinical data from 3 randomized, double-blind, PBO-controlled… The post Ascendis Pharma’s TransCon CNP (Navepegritide) Receives the CHMP’s Positive Opinion for Achondroplasia in Children appeared first on PharmaShots.

PharmaShots

Oct 16, 2026, 4:38 PM

Sobi and Ionis’ Tryngolza (Olezarsen) Receives the CHMP’s Positive Opinion for Severe Hypertriglyceridemia (sHTG)

Shots: The CHMP has adopted a positive opinion recommending the indication extension of Sobi’s Tryngolza (olezarsen) as an adjunct to diet, in combination with other lipid-lowering therapies, for adults with severe hypertriglyceridemia (sHTG; fasting TG ≥880 mg/dL [≥10 mmol/L]); if confirmed, it would be the first & only RNA-targeted therapy authorised in the EU for… The post Sobi and Ionis’ Tryngolza (Olezarsen) Receives the CHMP’s Positive Opinion for Severe Hypertriglyceridemia (sHTG) appeared first on PharmaShots.

PharmaShots

Oct 16, 2026, 4:36 PM

Johnson & Johnson’s Talvey (Talquetamab) + Daratumumab Receives the CHMP’s Positive Opinion for Relapsed/Refractory Multiple Myeloma

Shots: The CHMP has recommended approval of an indication extension for Johnson & Johnson’s Talvey (talquetamab) + daratumumab ± pomalidomide for adults with relapsed/refractory multiple myeloma (RRMM) who have received ≥1 prior therapy; if approved, it will be the only GPRC5D-targeting bispecific antibody combination for RRMM as early as 2L Recommendation was based on the… The post Johnson & Johnson’s Talvey (Talquetamab) + Daratumumab Receives the CHMP’s Positive Opinion for Relapsed/Refractory Multiple Myeloma appeared first on PharmaShots.

Pharma Tech

Oct 16, 2026, 1:48 PM

Can smarter technology selection help de-risk small-molecule development?

Predictive modelling for drug formulation helps developers select promising approaches and identify manufacturing challenges earlier.

News

Latest industry coverage

Google News

Oct 17, 2026, 7:41 PM

Ibn Sina pharma factory catches fire after Drug Int’l blaze in Gazipur - New Age BD

Ibn Sina pharma factory catches fire after Drug Int’l blaze in Gazipur  New Age BD

Google News

Oct 17, 2026, 7:00 PM

Five killed in blast at Bharuch pharma unit - The Times of India

Five killed in blast at Bharuch pharma unit  The Times of India

Google News

Oct 17, 2026, 4:59 PM

Cuba Prepares Workshop on Biosimilars, Innovation, and Access in Healthcare - teleSUR English

Cuba Prepares Workshop on Biosimilars, Innovation, and Access in Healthcare  teleSUR English

Google News

Oct 17, 2026, 4:41 PM

Merck Commits $2.9 Billion to Montgomery County Expansion - MyChesCo

Merck Commits $2.9 Billion to Montgomery County Expansion  MyChesCo

Google News

Oct 17, 2026, 2:22 PM

NPPA caps trade margins on 137 cancer drugs at 30%, revised prices from Nov 9 - The Economic Times

NPPA caps trade margins on 137 cancer drugs at 30%, revised prices from Nov 9  The Economic Times

Google News

Oct 17, 2026, 1:32 PM

Trump Slams Pharma And Insurers, But Rhetoric Outpaces Policy Impact - Forbes

Trump Slams Pharma And Insurers, But Rhetoric Outpaces Policy Impact  Forbes

Google News

Oct 17, 2026, 12:06 PM

Cleanroom Robots Healthcare Market To 2035: Biologics Sterility Demand Accelerates Adoption - News and Statistics - IndexBox

Cleanroom Robots Healthcare Market To 2035: Biologics Sterility Demand Accelerates Adoption - News and Statistics  IndexBox

Google News

Oct 17, 2026, 12:01 PM

AstraZeneca is a British behemoth. Why is it turning to America? - The Times

AstraZeneca is a British behemoth. Why is it turning to America?  The Times

Google News

Oct 17, 2026, 11:56 AM

GC Supplies And Consumables Market To 2035: Small-Molecule Drug Demand Supports Forward Growth - News and Statistics - IndexBox

GC Supplies And Consumables Market To 2035: Small-Molecule Drug Demand Supports Forward Growth - News and Statistics  IndexBox

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer